{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:23:49Z","timestamp":1768872229523,"version":"3.49.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/jcp.0b013e31818ce752","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T08:12:22Z","timestamp":1226477542000},"page":"723-725","source":"Crossref","is-referenced-by-count":26,"title":["Tactile and Visual Hallucinations in a Child With Methylphenidate and Fluoxetine Combination"],"prefix":"10.1097","volume":"28","author":[{"given":"Murat","family":"Coskun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih","family":"Zoroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"8","key":"R1-34-20210128","first-page":"945","article-title":"Methylphenidate and somatic hallucinations, J Am Acad Child Adolesc Psychiatry.","volume":"46","author":"Rashid","year":"2007","journal-title":""},{"key":"R2-34-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00004703-198106000-00003","article-title":"Methylphenidate-induced hallucinosis: case histories and possible mechanisms of action.","volume":"2","author":"Young","year":"1981","journal-title":"J Dev Behav Pediatr"},{"issue":"7","key":"R3-34-20210128","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1176\/ajp.2006.163.7.1149","article-title":"Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.","volume":"163","author":"Ross","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"8","key":"R4-34-20210128","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0006-3223(95)00195-M","article-title":"Fluoxetine and visual hallucinations in dementia.","volume":"38","author":"Omar","year":"1995","journal-title":"Biol Psychiatry"},{"key":"R5-34-20210128","first-page":"637","article-title":"Fluoxetine induced auditory hallucinations in an adolescent, J Paediatr Child Health.","volume":"39","author":"Webb","year":"2003","journal-title":""},{"key":"R6-34-20210128","first-page":"195","article-title":"Methylphenidate induced hallucinations: case report in Turkish.","volume":"17","author":"Abali","year":"2007","journal-title":"Bull Clin Psychopharmacol"},{"issue":"6","key":"R7-34-20210128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00004714-199812000-00012","article-title":"Visual hallucinations associated with fluoxetine and sertraline.","volume":"18","author":"Bourgeois","year":"1998","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"R8-34-20210128","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1176\/ajp.149.10.1406b","article-title":"Visual hallucinations after combining fluoxetine and dextromethorphan.","volume":"149","author":"Achamallah","year":"1992","journal-title":"Am J Psychiatry"},{"key":"R9-34-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/cap.1996.6.165","article-title":"Open-label treatment of comorbid depression and attentional disorder with co-administration of SRI's and psychostimulants in children, adolescents, and adults: a case series.","volume":"6","author":"Findling","year":"1996","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R10-34-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/cap.1993.3.1","article-title":"Methylphenidate in combination for treatment of attention-deficit disorder and comorbid depressive disorder.","volume":"3","author":"Gammon","year":"1993","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"11","key":"R11-34-20210128","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1176\/ajp.150.11.1750a","article-title":"Dopaminergic hallucinosis with fluoxetine in Parkinson's disease.","volume":"150","author":"Lauterbach","year":"1993","journal-title":"Am J Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e31818ce752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:58:10Z","timestamp":1620957490000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200812000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31818ce752","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}